在体外培养技术的进步,用于对人类肠道微生物群的全面分析
Young Sung Jung1, Nho-Eul Song2, Seo Yeong Oh3
1Korea Food Research Institute, Wanju, Jeollabuk-do 55365, Republic of Korea; Department of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.
Biotechnology advances
|May 15, 2025
概括
试管发酵模型为研究人类肠道微生物群提供了可控的替代方案,克服了临床试验和动物模型的局限性,以获得更好的健康见解.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 生物技术是生物技术.
背景情况:
- 人们越来越认识到人类肠道微生物群在健康和疾病中的作用.
- 传统的研究方法 (临床试验,动物模型) 在控制变量和复制人类肠道环境方面存在局限性.
- 在体内采集样本用于肠道微生物群分析,这带来了伦理和技术上的挑战.
研究的目的:
- 对人类肠道微生物群体体体外培养系统的当前知识和技术进步进行审查.
- 建立一个改善培养和研究肠道微生物群的方法框架.
- 加强研究方法,以了解微生物的相互作用和行为.
主要方法:
- 专注于体外培养系统的关键组成部分:三维支架,培养介质,发酵系统和分析技术.
- 对模拟人类肠道环境的技术进步进行审查.
- 检查微生物行为的受控研究方法.
主要成果:
- 试管发酵模型提供了一个受控的环境来模拟人类肠道的结构和功能特征.
- 技术进步正在提高这些模型的准确性和适用性.
- 这些系统为微生物的行为和适应提供了宝贵的见解.
结论:
- 试管发酵模型是研究人类肠道微生物群的有希望的替代方案.
- 培养系统的改进可以提高我们对微生物相互作用及其对健康的影响的理解.
- 本综述为推进肠道微生物种植和分析研究提供了一个框架.
相关概念视频
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...


